[1]
“Role of Rifaximin for the Treatment of Hepatic Encephalopathy in Chronic Liver Disease”, Birdem Med J, vol. 7, no. 3, pp. 205–211, Aug. 2017, doi: 10.3329/birdem.v7i3.33781.